{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:59:36Z","timestamp":1791464376807,"version":"4.3.4"},"reference-count":70,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cell.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Parasitology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.pt.2016.04.014","type":"journal-article","created":{"date-parts":[[2016,5,28]],"date-time":"2016-05-28T18:58:58Z","timestamp":1464461938000},"page":"697-707","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Phenotypic Screens in Antimalarial Drug Discovery"],"prefix":"10.1016","volume":"32","author":[{"given":"Marisa L.","family":"Hovlid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Winzeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pt.2016.04.014_bib0355","series-title":"World Malaria Report","author":"WHO","year":"2015"},{"key":"10.1016\/j.pt.2016.04.014_bib0370","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/415680a","article-title":"The economic and social burden of malaria","volume":"415","author":"Sachs","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.pt.2016.04.014_bib0375","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nrd4573","article-title":"Malaria medicines: a glass half full?","volume":"14","author":"Wells","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.pt.2016.04.014_bib0380","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1038\/507S4a","article-title":"Infectious disease: beating the big three","volume":"507","author":"Bourzac","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.pt.2016.04.014_bib0385","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1179\/2047773215Y.0000000013","article-title":"Killing the hypnozoite\u2013drug discovery approaches to prevent relapse in Plasmodium vivax","volume":"109","author":"Campo","year":"2015","journal-title":"Pathog. Glob. Health"},{"key":"10.1016\/j.pt.2016.04.014_bib0390","doi-asserted-by":"crossref","first-page":"10.1186","DOI":"10.1186\/1475-2875-12-187","article-title":"Designing the next generation of medicines for malaria control and eradication","volume":"12","author":"Burrows","year":"2013","journal-title":"Malar J."},{"key":"10.1016\/j.pt.2016.04.014_bib0395","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/nbt1015-1015","article-title":"Landmark green light for Mosquirix malaria vaccine","volume":"33","author":"Morrison","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.pt.2016.04.014_bib0400","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1056\/NEJMoa1505819","article-title":"Genetic diversity and protective efficacy of the RTS, S\/AS01 malaria vaccine","volume":"373","author":"Neafsey","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pt.2016.04.014_bib0405","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(15)60721-8","article-title":"Efficacy and safety of RTS,S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial","volume":"386","author":"RTS,S Clinical Trials Partnership","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.pt.2016.04.014_bib0410","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1314981","article-title":"Spread of artemisinin resistance in Plasmodium falciparum malaria","volume":"371","author":"Ashley","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pt.2016.04.014_bib0415","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2174\/1386207317666140109122450","article-title":"A perspective on 10-years HTS experience at the Walter and Eliza Hall Institute of Medical Research \u2013 eighteen million assays and counting","volume":"17","author":"Lackovic","year":"2014","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"10.1016\/j.pt.2016.04.014_bib0420","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.1016\/j.bmc.2012.04.062","article-title":"Early phase drug discovery: cheminformatics and computational techniques in identifying lead series","volume":"20","author":"Duffy","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.pt.2016.04.014_bib0425","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/clpt.2012.236","article-title":"Phenotypic vs. target-based drug discovery for first-in-class medicines","volume":"93","author":"Swinney","year":"2013","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.pt.2016.04.014_bib0430","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nrd4683","article-title":"Hit and lead criteria in drug discovery for infectious diseases of the developing world","volume":"14","author":"Katsuno","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.pt.2016.04.014_bib0435","doi-asserted-by":"crossref","first-page":"9059","DOI":"10.1073\/pnas.0802982105","article-title":"In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen","volume":"105","author":"Plouffe","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.pt.2016.04.014_bib0440","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nature09107","article-title":"Thousands of chemical starting points for antimalarial lead identification","volume":"465","author":"Gamo","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.pt.2016.04.014_bib0445","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nature09099","article-title":"Chemical genetics of Plasmodium falciparum","volume":"465","author":"Guiguemde","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.pt.2016.04.014_bib0450","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1128\/AAC.01927-13","article-title":"KAI407, a potent non-8-aminoquinoline compound that kills Plasmodium cynomolgi early dormant liver stage parasites in vitro","volume":"58","author":"Zeeman","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2016.04.014_bib0455","doi-asserted-by":"crossref","first-page":"18704","DOI":"10.1038\/srep18704","article-title":"A semi-automated luminescence based standard membrane feeding assay identifies novel small molecules that inhibit transmission of malaria parasites by mosquitoes","volume":"5","author":"Vos","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pt.2016.04.014_bib0460","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1021\/acsinfecdis.5b00143","article-title":"High-throughput luciferase-based assay for the discovery of therapeutics that prevent malaria","volume":"2","author":"Swann","year":"2016","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.pt.2016.04.014_bib0465","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.chom.2015.12.001","article-title":"High-throughput assay and discovery of small molecules that interrupt malaria transmission","volume":"19","author":"Plouffe","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.pt.2016.04.014_bib0470","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1126\/science.781840","article-title":"Human malaria parasites in continuous culture","volume":"193","author":"Trager","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.pt.2016.04.014_bib0475","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/1475-2875-13-190","article-title":"Screening and hit evaluation of a chemical library against blood-stage Plasmodium falciparum","volume":"13","author":"Avery","year":"2014","journal-title":"Malar J."},{"key":"10.1016\/j.pt.2016.04.014_bib0480","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature14451","article-title":"A novel multiple-stage antimalarial agent that inhibits protein synthesis","volume":"522","author":"Baragana","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.pt.2016.04.014_bib0485","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijpddr.2015.07.001","article-title":"The malaria parasite cation ATPase PfATP4 and its role in the mechanism of action of a new arsenal of antimalarial drugs","volume":"5","author":"Spillman","year":"2015","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.pt.2016.04.014_bib0490","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa1315860","article-title":"Spiroindolone KAE609 for falciparum and vivax malaria","volume":"371","author":"White","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pt.2016.04.014_bib0495","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nrmicro3138","article-title":"Antimalarial drug discovery \u2013 approaches and progress towards new medicines","volume":"11","author":"Flannery","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.pt.2016.04.014_bib0500","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-015-0962-2","article-title":"Identifying rapidly parasiticidal anti-malarial drugs using a simple and reliable in vitro parasite viability fast assay","volume":"14","author":"Linares","year":"2015","journal-title":"Malaria J."},{"key":"10.1016\/j.pt.2016.04.014_bib0505","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1089\/adt.2010.0308","article-title":"Cell-based screening using high-throughput flow cytometry","volume":"9","author":"Black","year":"2011","journal-title":"Assay Drug Deve. Technol."},{"key":"10.1016\/j.pt.2016.04.014_bib0510","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1475-2875-12-58","article-title":"Evaluation of bioluminescence-based assays of anti-malarial drug activity","volume":"12","author":"Hasenkamp","year":"2013","journal-title":"Malar J."},{"key":"10.1016\/j.pt.2016.04.014_bib0515","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1517\/14728222.2013.739158","article-title":"Targeting apicoplasts in malaria parasites","volume":"17","author":"Goodman","year":"2013","journal-title":"Exp. Opin. Ther. Targets"},{"key":"10.1016\/j.pt.2016.04.014_bib0520","first-page":"3490","article-title":"The apicoplast: a key target to cure malaria","volume":"18","author":"MacRae","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.pt.2016.04.014_bib0525","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1096\/fj.11-187401","article-title":"Identifying apicoplast-targeting antimalarials using high-throughput compatible approaches","volume":"25","author":"Ekland","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.pt.2016.04.014_bib0530","doi-asserted-by":"crossref","first-page":"e1001138","DOI":"10.1371\/journal.pbio.1001138","article-title":"Chemical rescue of malaria parasites lacking an apicoplast defines organelle function in blood-stage Plasmodium falciparum","volume":"9","author":"Yeh","year":"2011","journal-title":"PLoS Biol."},{"key":"10.1016\/j.pt.2016.04.014_bib0535","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1128\/AAC.01500-13","article-title":"Antiapicoplast and gametocytocidal screening to identify the mechanisms of action of compounds within the malaria box","volume":"58","author":"Bowman","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2016.04.014_bib0540","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1128\/AAC.03342-14","article-title":"A chemical rescue screen identifies a Plasmodium falciparum apicoplast inhibitor targeting MEP isoprenoid precursor biosynthesis","volume":"59","author":"Wu","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2016.04.014_bib0545","doi-asserted-by":"crossref","first-page":"13891","DOI":"10.1038\/srep13891","article-title":"High-throughput matrix screening identifies synergistic and antagonistic antimalarial drug combinations","volume":"5","author":"Mott","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pt.2016.04.014_bib0550","doi-asserted-by":"crossref","first-page":"e1000406","DOI":"10.1371\/journal.pmed.1000406","article-title":"A research agenda to underpin malaria eradication","volume":"8","author":"Alonso","year":"2011","journal-title":"PLoS Med."},{"key":"10.1016\/j.pt.2016.04.014_bib0555","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1128\/CMR.15.3.355-364.2002","article-title":"Cultivation of Plasmodium spp","volume":"15","author":"Schuster","year":"2002","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.pt.2016.04.014_bib0560","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4269\/ajtmh.1985.34.21","article-title":"In vitro cultivation of the exoerythrocytic stage of Plasmodium berghei in irradiated hepatoma cells","volume":"34","author":"Hollingdale","year":"1985","journal-title":"Am. J. Trop Med. Hyg."},{"key":"10.1016\/j.pt.2016.04.014_bib0565","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1128\/AAC.50.4.1586-1589.2006","article-title":"New approach for high-throughput screening of drug activity on Plasmodium liver stages","volume":"50","author":"Gego","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2016.04.014_bib0570","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1126\/science.1211936","article-title":"Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery","volume":"334","author":"Meister","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.pt.2016.04.014_bib0575","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.1021\/jm2003359","article-title":"Imidazolopiperazines: hit to lead optimization of new antimalarial agents","volume":"54","author":"Wu","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pt.2016.04.014_bib0580","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1021\/jm300041e","article-title":"Imidazolopiperazines: lead optimization of the second-generation antimalarial agents","volume":"55","author":"Nagle","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pt.2016.04.014_bib0585","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1128\/AAC.02727-13","article-title":"KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission","volume":"58","author":"Kuhen","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2016.04.014_bib0590","doi-asserted-by":"crossref","DOI":"10.1021\/acsinfecdis.6b00025","article-title":"Plasmodium falciparum cyclic amine resistance locus, PfCARL: a resistance mechanism for two distinct compound classes","author":"Magistrado","year":"2016","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.pt.2016.04.014_bib0360","doi-asserted-by":"crossref","first-page":"6437","DOI":"10.1128\/AAC.03478-14","article-title":"A first-in-human randomized, double-blind, placebo-controlled, single- and multiple-ascending oral dose study of novel imidazolopiperazine KAF156 to assess its safety, tolerability, and pharmacokinetics in healthy adult volunteers","volume":"58","author":"Leong","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2016.04.014_bib0595","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1093\/infdis\/jis184","article-title":"Drug screen targeted at Plasmodium liver stages identifies a potent multistage antimalarial drug","volume":"205","author":"da Cruz","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.pt.2016.04.014_bib0600","doi-asserted-by":"crossref","first-page":"8511","DOI":"10.1073\/pnas.1118370109","article-title":"Liver-stage malaria parasites vulnerable to diverse chemical scaffolds","volume":"109","author":"Derbyshire","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S. A."},{"key":"10.1016\/j.pt.2016.04.014_bib0605","article-title":"Discovery of dual stage malaria inhibitors with new targets","author":"Raphemot","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2016.04.014_bib0610","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1186\/1475-2875-10-351","article-title":"Primaquine in vivax malaria: an update and review on management issues","volume":"10","author":"Fernando","year":"2011","journal-title":"Malar J."},{"key":"10.1016\/j.pt.2016.04.014_bib0615","first-page":"CD010458","article-title":"Tafenoquine for preventing relapse in people with Plasmodium vivax malaria","volume":"4","author":"Rajapakse","year":"2015","journal-title":"Cochrane Database of Syst. Rev."},{"key":"10.1016\/j.pt.2016.04.014_bib0365","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4269\/ajtmh.2007.76.203","article-title":"Regional differences in the response of Plasmodium vivax malaria to primaquine as anti-relapse therapy","volume":"76","author":"Goller","year":"2007","journal-title":"Am. J. Trop Med. Hyg."},{"key":"10.1016\/j.pt.2016.04.014_bib0620","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.4269\/ajtmh.1977.26.1116","article-title":"Radical cure of infections with Plasmodium cynomolgi: a function of total 8-aminoquinoline dose","volume":"26","author":"Schmidt","year":"1977","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2016.04.014_bib0625","doi-asserted-by":"crossref","first-page":"e18162","DOI":"10.1371\/journal.pone.0018162","article-title":"Towards an in vitro model of Plasmodium hypnozoites suitable for drug discovery","volume":"6","author":"Dembele","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.pt.2016.04.014_bib0630","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nature12782","article-title":"Targeting Plasmodium PI(4)K to eliminate malaria","volume":"504","author":"McNamara","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.pt.2016.04.014_bib0635","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nm.3461","article-title":"Persistence and activation of malaria hypnozoites in long-term primary hepatocyte cultures","volume":"20","author":"Demb\u00e9l\u00e9","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.pt.2016.04.014_bib0640","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1517\/17460441.2015.1032241","article-title":"The application of engineered liver tissues for novel drug discovery","volume":"10","author":"Lin","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.pt.2016.04.014_bib0645","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.chom.2015.02.011","article-title":"Plasmodium vivax liver stage development and hypnozoite persistence in human liver-chimeric mice","volume":"17","author":"Mikolajczak","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.pt.2016.04.014_bib0650","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1186\/1475-2875-12-408","article-title":"Identification of inhibitors of Plasmodium falciparum gametocyte development","volume":"12","author":"Duffy","year":"2013","journal-title":"Malar J."},{"key":"10.1016\/j.pt.2016.04.014_bib0655","doi-asserted-by":"crossref","first-page":"e0135139","DOI":"10.1371\/journal.pone.0135139","article-title":"A new set of chemical starting points with Plasmodium falciparum transmission-blocking potential for antimalarial drug discovery","volume":"10","author":"Almela","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.pt.2016.04.014_bib0660","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1093\/jac\/dkt165","article-title":"A Plasmodium falciparum screening assay for anti-gametocyte drugs based on parasite lactate dehydrogenase detection","volume":"68","author":"D\u2019Alessandro","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.pt.2016.04.014_bib0665","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.molbiopara.2013.02.005","article-title":"A quantitative high throughput assay for identifying gametocytocidal compounds","volume":"188","author":"Tanaka","year":"2013","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.pt.2016.04.014_bib0670","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1128\/AAC.04684-14","article-title":"Imaging-based high-throughput screening assay to identify new molecules with transmission-blocking potential against Plasmodium falciparum female gamete formation","volume":"59","author":"Miguel-Blanco","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pt.2016.04.014_bib0675","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.molbiopara.2011.09.002","article-title":"A high-throughput assay for the identification of drugs against late-stage Plasmodium falciparum gametocytes","volume":"180","author":"Peatey","year":"2011","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.pt.2016.04.014_bib0680","doi-asserted-by":"crossref","first-page":"E1214","DOI":"10.1073\/pnas.1112037108","article-title":"Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blue","volume":"108","author":"Adjalley","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.pt.2016.04.014_bib0685","doi-asserted-by":"crossref","first-page":"16414","DOI":"10.1038\/srep16414","article-title":"A simple and predictive phenotypic high content Imaging assay for Plasmodium falciparum mature gametocytes to identify malaria transmission blocking compounds","volume":"5","author":"Lucantoni","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pt.2016.04.014_bib0690","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1017\/S0031182004006067","article-title":"Evaluation of the standard membrane feeding assay (SMFA) for the determination of malaria transmission-reducing activity using empirical data","volume":"130","author":"van der Kolk","year":"2005","journal-title":"Parasitology"},{"key":"10.1016\/j.pt.2016.04.014_bib0695","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/cmi.12413","article-title":"The cell biology of malaria infection of mosquito: advances and opportunities","volume":"17","author":"Sinden","year":"2015","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.pt.2016.04.014_bib0700","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1098\/rstb.2011.0091","article-title":"Vaccines against malaria","volume":"366","author":"Hill","year":"2011","journal-title":"Philos. Trans R. Soc. Lond. B Biol. Sci."}],"container-title":["Trends in Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492216300319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492216300319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T00:53:53Z","timestamp":1567990433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471492216300319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":70,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S1471492216300319"],"URL":"https:\/\/doi.org\/10.1016\/j.pt.2016.04.014","relation":{},"ISSN":["1471-4922"],"issn-type":[{"value":"1471-4922","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenotypic Screens in Antimalarial Drug Discovery","name":"articletitle","label":"Article Title"},{"value":"Trends in Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pt.2016.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}